title: Bcl6 is expressed in neuroblastoma: tumor cell type-specific expression predicts outcome.
abstract: Neuroblastoma (NB) is the most common extracranial solid neoplasm of infancy and childhood. Whereas most low-risk patients do well, children with high-risk tumors often fail intensive treatment. Identification of novel biomarkers is critical to improve prognostication, tailor therapy, and develop new therapeutic targets. Differential RNA-level expression between tumor cells with neuroblastic (N-type) and Schwannian stromal (S-type) phenotypes was used to identify genes of potential interest based on tumor cell type-specific regulation. Gene expression microarray analysis revealed marked differences between N-type and S-type cells in their levels of BCL6 messenger RNA, a transcriptional regulator overexpressed in a variety of hematopoietic malignancies. S-type cells express higher levels of Bcl6 RNA and protein than N-type, and protein levels are significantly limited by proteasome function. An NB tumor tissue microarray linked to clinicopathologic data was immunohistochemically stained to measure Bcl6 protein levels. Bcl6 was detected in both the neuroblastic and Schwannian stromal regions, as distinguished histologically, and correlated with outcome. We found that expression in neuroblastic regions differentiates outcomes, in that Bcl6 expression in neuroblastic regions is associated with increased time to relapse and increased overall survival compared with absent expression in neuroblastic regions, regardless of Schwannian stromal expression. Thus, our findings suggest that Bcl6 may be useful as a prognostic marker and might represent a potential therapeutic target for high-risk NB.
authors.affiliation: Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
authors.forename: Aghiad
authors.initials: A
authors.lastname: Chamdin
authors.forename: Jason A
authors.initials: JA
authors.lastname: Jarzembowski
authors.forename: Chitra
authors.initials: C
authors.lastname: Subramanian
authors.forename: Rork
authors.initials: R
authors.lastname: Kuick
authors.forename: Julia Shin-Jung
authors.initials: JS
authors.lastname: Lee
authors.forename: Roland Ps
authors.initials: RP
authors.lastname: Kwok
authors.forename: Valerie P
authors.initials: VP
authors.lastname: Castle
authors.forename: Anthony W
authors.initials: AW
authors.lastname: Opipari
references.citation: Blood. 1995 Jul 1;86(1):28-37
references.pmid: 7795234
references.citation: Cancer Res. 1989 Jan 1;49(1):219-25
references.pmid: 2535691
references.citation: Am J Clin Pathol. 2004 Jan;121(1):34-42
references.pmid: 14750238
references.citation: Am J Pathol. 2001 Oct;159(4):1231-8
references.pmid: 11583950
references.citation: OMICS. 2003 Fall;7(3):235-52
references.pmid: 14583114
references.citation: J Clin Oncol. 2000 Jul;18(13):2582-92
references.pmid: 10893290
references.citation: Blood. 2003 Jan 15;101(2):706-10
references.pmid: 12393409
references.citation: Nat Immunol. 2005 Oct;6(10):1054-60
references.pmid: 16142238
references.citation: Cancer Cell. 2006 Jun;9(6):435-43
references.pmid: 16766263
references.citation: Oncogene. 1996 Jun 6;12(11):2331-42
references.pmid: 8649773
references.citation: J Clin Oncol. 1999 Jul;17(7):2264-79
references.pmid: 10561284
references.citation: Nat Immunol. 2007 Jul;8(7):705-14
references.pmid: 17558410
references.citation: Cancer Cell. 2005 May;7(5):445-55
references.pmid: 15894265
references.citation: Pediatr Blood Cancer. 2007 Mar;48(3):311-7
references.pmid: 16609945
references.citation: Curr Opin Pediatr. 2005 Feb;17(1):7-13
references.pmid: 15659956
references.citation: Pathol Int. 1997 Sep;47(9):600-7
references.pmid: 9311010
references.citation: J Clin Oncol. 2005 Dec 1;23(34):8819-27
references.pmid: 16314642
references.citation: Carcinogenesis. 2004 Oct;25(10):1839-46
references.pmid: 15155532
references.citation: Genes Chromosomes Cancer. 2007 Oct;46(10):936-49
references.pmid: 17647283
references.citation: Oncogene. 2003 Aug 28;22(36):5572-8
references.pmid: 12944904
references.citation: J Immunol. 2002 Aug 15;169(4):1922-9
references.pmid: 12165517
references.citation: Nature. 2004 Dec 2;432(7017):635-9
references.pmid: 15577913
references.citation: Nat Immunol. 2007 Oct;8(10):1132-9
references.pmid: 17828269
references.citation: Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12520-4
references.pmid: 8618933
references.citation: Cancer Res. 1999 Sep 1;59(17):4392-9
references.pmid: 10485488
references.citation: Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):6947-52
references.pmid: 8692924
references.citation: N Engl J Med. 1996 Jun 6;334(23):1505-11
references.pmid: 8618605
references.citation: Clin Cancer Res. 2003 Dec 15;9(17):6316-25
references.pmid: 14695130
references.citation: Genes Dev. 1998 Jul 1;12(13):1953-61
references.pmid: 9649500
references.citation: Cancer Res. 2001 Sep 15;61(18):6892-8
references.pmid: 11559566
references.citation: Blood. 2001 Aug 15;98(4):945-51
references.pmid: 11493437
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4842-7
references.pmid: 15778293
references.citation: Nat Med. 2003 Jul;9(7):969-73
references.pmid: 12819780
references.citation: Cell Growth Differ. 1995 Apr;6(4):449-56
references.pmid: 7794812
references.citation: J Biol Chem. 2001 Dec 28;276(52):48921-9
references.pmid: 11679590
references.citation: Blood. 1995 Jul 1;86(1):45-53
references.pmid: 7795255
references.citation: BMC Bioinformatics. 2005 Feb 10;6:26
references.pmid: 15705192
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11816-21
references.pmid: 9751748
references.citation: Biochim Biophys Acta. 2006 Oct;1763(10):1000-10
references.pmid: 16979248
references.citation: Pathol Biol (Paris). 2007 Feb;55(1):73-83
references.pmid: 16815642
references.citation: Nat Rev Cancer. 2003 Mar;3(3):203-16
references.pmid: 12612655
references.citation: Ann Oncol. 1999 Jun;10(6):715-21
references.pmid: 10442195
references.citation: Cancer. 1999 Jul 15;86(2):364-72
references.pmid: 10421273
references.citation: Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15018-23
references.pmid: 12407182
references.citation: Cancer Res. 1987 Mar 1;47(5):1383-9
references.pmid: 3028608
references.citation: N Engl J Med. 2005 Nov 24;353(21):2243-53
references.pmid: 16306521
references.citation: Lancet. 2007 Jun 23;369(9579):2106-20
references.pmid: 17586306
references.citation: Oncogene. 2006 Apr 6;25(15):2223-33
references.pmid: 16331266
references.citation: Cancer Res. 1987 Dec 15;47(24 Pt 1):6505-10
references.pmid: 2445473
references.citation: Cancer. 1999 Jul 15;86(2):349-63
references.pmid: 10421272
references.citation: Oncogene. 1995 Dec 21;11(12):2689-97
references.pmid: 8545127
references.citation: Clin Cancer Res. 2003 Mar;9(3):1063-9
references.pmid: 12631608
references.citation: Cancer. 2008 Jan 1;112(1):151-6
references.pmid: 17999414
references.citation: Am J Med Genet. 1994 Oct 15;53(1):24-8
references.pmid: 7802031
references.citation: Cancer Lett. 2003 Jul 18;197(1-2):35-9
references.pmid: 12880957
references.citation: Blood. 2006 Feb 15;107(4):1599-607
references.pmid: 16249378
references.citation: Exp Cell Res. 2004 May 1;295(2):469-87
references.pmid: 15093745